Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) FCF Margin (2018 - 2025)

Viemed Healthcare (VMD) has disclosed FCF Margin for 6 consecutive years, with 65.22% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 138.0% year-over-year to 65.22%, compared with a TTM value of 19.21% through Dec 2025, up 275.0%, and an annual FY2025 reading of 19.21%, up 275.0% over the prior year.
  • FCF Margin was 65.22% for Q4 2025 at Viemed Healthcare, up from 12.41% in the prior quarter.
  • Across five years, FCF Margin topped out at 65.22% in Q4 2025 and bottomed at 18.05% in Q3 2024.
  • Average FCF Margin over 5 years is 18.84%, with a median of 17.14% recorded in 2021.
  • Peak annual rise in FCF Margin hit 3769bps in 2024, while the deepest fall reached -6777bps in 2024.
  • Year by year, FCF Margin stood at 27.08% in 2021, then fell by -24bps to 20.49% in 2022, then increased by 28bps to 26.16% in 2023, then surged by 144bps to 63.84% in 2024, then rose by 2bps to 65.22% in 2025.
  • Business Quant data shows FCF Margin for VMD at 65.22% in Q4 2025, 12.41% in Q3 2025, and 18.91% in Q2 2025.